ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $24M
- 5-year CAGR
- +255.0%
- 10-year CAGR
- +44.8%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $24M | — |
| 2023 | $686K | +23.4% |
| 2022 | $556K | +11.9% |
| 2021 | $497K | +1,055.8% |
| 2020 | $43K | −71.5% |
| 2019 | $151K | −44.7% |
| 2018 | $273K | −40.4% |
| 2017 | $458K | −20.5% |
| 2016 | $576K | −3.8% |
| 2015 | $599K | −7.4% |
| 2014 | $647K | +128.6% |
| 2013 | $283K | −7.5% |
| 2012 | $306K | −0.6% |
| 2011 | $308K | −32.8% |
| 2010 | $458K | −45.8% |
| 2009 | $845K | +55.0% |
| 2008 | $545K | +990.0% |
| 2007 | $50K | +28.2% |
| 2006 | $39K | — |